<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The effect of <z:chebi fb="0" ids="9342">sulfinpyrazone</z:chebi> on various parameters of platelet function was studied in volunteers </plain></SENT>
<SENT sid="1" pm="."><plain>The shape change, adhesivity and aggregability of thrombocytes were significantly decreased after an oral treatment with 200 mg Anturano t.d.s. for seven days </plain></SENT>
<SENT sid="2" pm="."><plain>Two days after the last medication this effect was still evident </plain></SENT>
<SENT sid="3" pm="."><plain>In addition an experimental <z:mp ids='MP_0005048'>thrombosis</z:mp> was performed in rats by chilling a standardized segment of the carotid artery </plain></SENT>
<SENT sid="4" pm="."><plain>After previous application of 10 and 100 mg/kg BW of <z:chebi fb="0" ids="9342">sulfinpyrazone</z:chebi> the <z:e sem="disease" ids="C0302148,C0087086" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">thrombus</z:e> formation was significantly decreased in comparison with the control group </plain></SENT>
</text></document>